Literature DB >> 16265613

Investigating neurocognitive features of hepatitis C virus infection in drug users: potential challenges and lessons learned from the HIV literature.

Raul Gonzalez1, Joanna Jacobus, Eileen M Martin.   

Abstract

Studies of neurocognition in drug users with hepatitis C virus (HCV) infection are urgently needed but face many challenges. We review similarities between human immunodeficiency virus (HIV) and HCV infection in their neurocognitive features, discuss challenges associated with research among drug users, advocate that the HIV literature can usefully inform studies of HCV, and review findings by our group on neurocognition among substance users with HIV and/or HCV infection.

Entities:  

Mesh:

Year:  2005        PMID: 16265613     DOI: 10.1086/429495

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.

Authors:  Roman Shrestha; Frederick L Altice; Brian Sibilio; Jude Ssenyonjo; Michael M Copenhaver
Journal:  Contemp Clin Trials       Date:  2019-06-20       Impact factor: 2.226

2.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

3.  Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment.

Authors:  Tania B Huedo-Medina; Roman Shrestha; Michael Copenhaver
Journal:  AIDS Behav       Date:  2016-08

Review 4.  Underlying pathophysiology of HCV infection in HIV-positive drug users.

Authors:  Anuradha Balasubramanian; Jerome E Groopman; Ramesh K Ganju
Journal:  J Addict Dis       Date:  2008

5.  Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients.

Authors:  D B Clifford; M Smurzynski; L S Park; T-M Yeh; Y Zhao; L Blair; M Arens; S R Evans
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

Review 6.  Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features.

Authors:  Eileen M Martin-Thormeyer; Robert H Paul
Journal:  Neuropsychol Rev       Date:  2009-05-27       Impact factor: 7.444

7.  Clinical care of the HIV-infected drug user.

Authors:  R Douglas Bruce; Frederick L Altice
Journal:  Infect Dis Clin North Am       Date:  2007-03       Impact factor: 5.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.